J2KBIO Co., Ltd. (KOSDAQ:420570)
7,490.00
+290.00 (4.03%)
At close: Jun 29, 2026
-25.10% (1Y)
| Market Cap | 43.80B -29.7% |
| Revenue (ttm) | 36.82B +13.0% |
| Net Income | 4.03B +39.4% |
| EPS | 690.98 +36.0% |
| Shares Out | 5.85M |
| PE Ratio | 10.84 |
| Forward PE | n/a |
| Dividend | 250.00 (3.47%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 14,200 |
| Open | 7,150.00 |
| Previous Close | 7,200.00 |
| Day's Range | 7,000.00 - 7,630.00 |
| 52-Week Range | 6,710.00 - 11,850.00 |
| Beta | 0.43 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 12, 2026 |